Qualigen Therapeutics Inc (QLGN NASDAQ) stock market data APIs
$2.0402
0.04(2%)
as of September 15, 2025
Try our APIs with
free plan!
Qualigen Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase I clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. The company was founded in 1996 and is based in Carlsbad, California.
Prev. Close
2.0402
Open
2.0816
High
2.0816
Low
1.9842
52 wk Range
1.61-10.45
Market Cap
3 552 K
P/E Ratio
0.3315
Shares Outstanding
1 695 K
Revenue
4 984 K
EPS
-1.0019
Beta
-0.154
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Qualigen Therapeutics Inc data using free add-ons & libraries
Get Qualigen Therapeutics Inc Fundamental Data
Qualigen Therapeutics Inc Fundamental data includes:
- Net Revenue: 4 984 K
- EBITDA: -6 886 340
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-18
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Qualigen Therapeutics Inc News
New
Notable Two Hundred Day Moving Average Cross - LNW
In trading on Tuesday, shares of Light & Wonder Inc (Symbol: LNW) crossed below their 200 day moving average of $92.52, changing hands as low as $89.24 per share. Light & Wonder Inc shares are curren...
Qualigen Therapeutics Provides Update on Nasdaq Communications and Continued Listing Status
CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) received two different communications from the staff of the Nasdaq Listing Qualific...
Qualigen Therapeutics Provides Update on Nasdaq Communications and Continued Listing Status
Qualigen Therapeutics, Inc. CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) received two different communications from the staff of ...
Qualigen Therapeutics Announces $4.5 Million Private Placement of Series A-3 Convertible Preferred Stock
Carlsbad, CA, July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or the "Company"), a life sciences company focused on developing platform treatments for adult a...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
